Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
- Cardiovascular diseases
- Lipid metabolism
- Pain research
Prof Dr Drexel spoke at ISCP 2018 in Kyoto, Japan:
Prevention of Atherosclerotic Events by Targeting Lipid Metabolism and Inflammation: PCSK9-Inhibitors For Which Patient?
To watch featured sessions from ISCP 2018, including Dr Drexel, please visit our conference talks section: